The skyrocketing cost of weight-loss drugs has state Medicaid programs looking for a solution

Some of the more than a dozen states that cover GLP-1 drugs like Wegovy, Ozempic and Zepbound through Medicaid are scrambling to lessen the budgetary squeeze from fast-rising costs.

Featured image description: This image shows a person sitting on a red, upholstered bench in a grand interior space. The setting features ornate architectural details, such as decorative columns and intricate wall patterns. The person is wearing glasses, a black jacket, and a patterned dress.